drugset / Trial / NCT00002400

A Study of Two Anti-HIV Drug Combinations in HIV-Infected Patients

NCT00002400 ↗

Completed 45 enrolled Pharmacia and Upjohn
Treatment

Summary

The purpose of this study is to compare the safety and effectiveness of giving HIV-infected patients delavirdine (DLV) plus zidovudine (ZDV) plus 2 doses of indinavir (IDV) or ZDV plus IDV plus lamivudine (3TC). This study also examines how the body processes DLV when it is given in combination with other drugs.

Timeline

Start
—
Primary completion
—
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject Delavirdine Small molecule — —
Subject INDINAVIR ANHYDROUS Other / unclassified — —
Subject Lamivudine Other / unclassified — —
Subject Zidovudine Small molecule — —